ZBIO
Zenas BioPharma Inc.
Company Overview
| Mkt Cap | $1.27B | Price | $31.15 |
| Volume | 278.12K | Change | -0.32% |
| P/E Ratio | -8.1 | Open | $31.17 |
| Revenue | $5.0M | Prev Close | $31.25 |
| Net Income | $-157.0M | 52W Range | $5.83 - $34.33 |
| Div Yield | N/A | Target | $43.14 |
| Overall | 58 | Value | 60 |
| Quality | 42 | Technical | 72 |
No chart data available
Stock Overview
Updated DailyZenas BioPharma Inc. (ZBIO) is a leading diversified company in the business industry, currently trading at $31.15 with a market capitalization of $1.27 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows ZBIO with a volume of 278K shares. The stock opened down 0.26% from yesterday's close of $31.25. Current analyst estimates project earnings of $-3.63 per share for this year, with next year targeting $-4.7.
ZBIO demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for ZBIO include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 38.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 4, 2025 at 05:05 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZBIO | $31.15 | -0.3% | 278.12K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |